Form 4: Clene Inc. Director Jonathon Gay Acquires Stock Options
SEC Form 4
Clene Inc. director Jonathon Gay was granted stock options for 3,673 shares of common stock at an exercise price of $4.40 per share.
Summary
- Director Jonathon Gay of Clene Inc. was granted stock options on December 6, 2024.
- The options are for 3,673 shares of common stock.
- The exercise price for these options is $4.40 per share.
- The options vest immediately upon grant.
- The options expire on December 5, 2034.
Sentiment
Score: 7
Explanation: The document reflects a standard practice of granting stock options to a director, which is generally viewed positively as it aligns interests. There are no negative implications.
Positives
- The immediate vesting of the options suggests a strong incentive for the director.
- The grant of options aligns the director's interests with those of the shareholders.
Industry Context
This is a standard practice for incentivizing directors and aligning their interests with the company's performance.
Comparison to Industry Standards
- Stock option grants to directors are a common practice in publicly traded companies, particularly in the biotech sector.
- The vesting schedule of immediately vesting is not uncommon, but can vary depending on the company's compensation policies.
- The exercise price of $4.40 is a specific value for this company and would need to be compared to the current market price of the stock to assess its value.
Stakeholder Impact
- Shareholders may view this positively as it aligns the director's interests with the company's success.
- The director is incentivized to increase the value of the company's stock.
Key Dates
| Date | Description |
|---|---|
| 12/06/2024 | Date of the stock option grant. |
| 12/05/2034 | Expiration date of the stock options. |
| 12/09/2024 | Date of the signature on the form. |
Keywords
stock options, insider trading, director, equity, Clene Inc., CLNN, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.